UCSF PANC Cyst Registry
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT04291651
- Status
- Recruiting
Conditions
- Intraductal Papillary Mucinous Neoplasm
- Mucinous Cyst
- Pancreatic Cancer
- Pancreatic Cyst
- Pancreatic Diseases
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Intraductal Papillary Mucinous Neoplasm
- Pancreatic Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Survey — OTHERThere are no study-specific interventions, as this is a prospective registry. However, patients will be asked to complete approximately 1-2 hours worth of surveys on things such as demographics, medical and surgical history, and pancreatic cyst-specific questionnaires.
Study Details
Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.
Key Dates
- Start date
- Oct 8, 2019
- Status verified
- Sep 2025
- Primary completion
- Jan 1, 2030
- Completion
- Jan 1, 2030
Study Design
- Enrollment
- 4,000 participants (estimated)
Arms
- Arm: RetrospectiveThe registry will be populated with a retrospective cohort of patients previously identified as having pancreatic cysts.
- Arm: ProspectiveThe prospectively enrolled patients in this study are the primary population of interest.
Primary Outcome Measure
Cancer [ Time Frame: 1-10 years ]
Central Contacts
- Charysa Santos, BS415-514-6914
- Kimberly S Kirkwood, MD415-502-5577
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | Kimberly Kirkwood, MD (PRINCIPAL_INVESTIGATOR) Paige M Bracci, PhD, MPH, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) RegistryRecruiting · University of Louisville · Birmingham, Alabama
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas CancerRecruiting · Stanford University · Stanford, California
- Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Recruiting · M.D. Anderson Cancer Center · Los Angeles, California